BioCatalyst

Oral Lenacapavir, Subcutaneous Lenacapavir, Optimized Background Regimen (OBR) — catalyst calendar

1 verified catalyst event(s) referencing Oral Lenacapavir, Subcutaneous Lenacapavir, Optimized Background Regimen (OBR), each linked to its official source. Verified as of 2026-10-29.

Upcoming

DateEventCompanyDrugOfficial source & verification
2027-03 (month)
in 4mo
ESTIMATED
 READOUT
Evaluation of Long-Acting Lenacapavir for the Treatment of HIV-1 in Treatment-ex
Phase 2 · HIV-1-infection
 GILD GILEAD SCIENCES, INC. Oral Lenacapavir, Subcutaneous Lenacapav ClinicalTrials.gov ↗
✓ Source-checked 2026-10-29
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.